. Author manuscript; available in PMC: 2010 Jun 14.

Published in final edited form as: Bone Marrow Transplant. 2009 May 11;45(1):13–19. doi: 10.1038/bmt.2009.90

Table 2.

Frequency of MBL Exon-1 and X/Y promoter polymorphisms MBL Genotype Recipient

MBL Genotype	Recipient n (%)	Donor n (%)
YA/YA	48 (36.6)	46 (35.1)
YA/XA	30 (22.9)	32 (24.4)
XA/XA	9 (6.9)	6 (4.6)
Wildtype (A/A)	87 (66.4)	84 (64.1)
YA/YD	12 (9.2)	17 (13.0)
YA/YB+YC	20 (15.2)	15 (11.5)
XA/YD	3 (2.3)	2 (1.5)
XA/YB+YC	3 (2.3)	2 (1.5)
Heterozygous (A/O)	38 (29.0)	36 (27.5)
Homozygous (O/O)	5 (3.8)	10 (7.6)
Missing	1 (0.8)	1 (0.8)
Total	131 (100)	131 (100)

Patients with either YA/YA, YA/XA, XA/XA or genotype were summarized as A/A; YA/YD, YA/YB+YC, XA/YD or XA/YB+YC patients were defined as A/O and patients with YO/YO MBL genotype as O/O.